BackhausJJunghannsKBornJ. (2006) Impaired declarative memory consolidation during sleep in patients with primary insomnia: influence of sleep architecture and nocturnal cortisol release. Biol Psychiat60: 1324–1330.
2.
ButlerGKLMontgomeryAMJ (2004) Impulsivity, risk taking and recreational ‘ecstasy’ (MDMA) use. Drug Alc Depend76: 55–62.
3.
DarveshASGudelskyGA (2005) Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res21: 168–175.
4.
Den HollanderBSchouwMGrootPHuismanHCannMBarkhofF. (2011) Preliminary evidence of hippocampal damage in chronic users of ecstasy. J Neurol Neurosurg Psychiat83: 83–85.
5.
ErritzoeDFrokjaerVGHolstKKChristoffersenMJohansenSSSvarerC. (2011) In vivo imaging of cerebral serotonin transporter and serotonin (2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) and hallucinogen users. Arch Gen Psychiat68: 562–576.
6.
FishbeinDHLozovskyDJaffeJH (1989) Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiat25: 1049–1066.
7.
FoxHCMcLeanATurnerJJDParrottACRogersRSahakianBJ (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology162: 203–214.
8.
GerraGBassignanaSZaimovicAMoiGBussandriMCaccavariC. (2003) Hypothalamic–pituitary–adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity. Psychiatry Res120: 115–124.
9.
HarrisDSBaggottMMendelsonJHMendelsonJEJonesRT (2002) Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology162: 396–405.
10.
HerbertJGoodyerIMGrossmanABHastingsMHde KloetERLightmanSL. (2007) Do corticosteroids damage the brain?J Neuroendocrinol18: 393–411.
11.
JacobsenLKMenclWEPughKRSkudlarskiPKrystalJH (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects. Psychopharmacology173: 383–390.
12.
KishSJLerchJFurukawaYTongJMcCluskeyTWilkinsD. (2010) Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain133: 1779–1797.
13.
McCannUDSgambatiFPSchwartzARRicaurteGA (2009) Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers. Neurology73: 2011–2017.
14.
McMorrisTSwainJSmithMCorbettJDelvesSSaleC. (2006) Heat stress, plasma concentrations of adrenaline, noradrenaline, 5-hydroxytryptamine and cortisol, mood state and cognitive performance. Int J Psychophysiol6: 204–215.
15.
MontgomeryCHattonNPFiskJEOgdenRSJansariA (2010) Assessing the functional significance of ecstasy-related memory deficits using a virtual reality paradigm. Hum Psychopharmacol25: 318–325.
16.
MorefieldKMKeaneMFelgatePWhiteJMIrvineRJ (2009) The acute psychobiological impacts of illicit 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) consumption in recreational environments. Neuropsychobiology60: 216–217.
17.
NagarajaNAndradeCSudhaSMadan SinghNChandraJSVenkataramanBV (2007) Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology190: 73–80.
18.
ParrottAC (2004) MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology50: 329–335.
19.
ParrottAC (2006) MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol20: 147–163.
20.
ParrottAC (2009) Cortisol and MDMA (3,4-methylenedioxymethamphetamine): neurohormonal aspects of bioenergetic-stress in Ecstasy users. Neuropsychobiology60: 148–158.
21.
ParrottACAdnumLEvansAKisslingCThomeJ (2007) Heavy Ecstasy/MDMA use at cool house parties: substantial cortisol release and increased body temperature. J Psychopharmacol21: a35.
22.
ParrottACLaskyJ (1998) Ecstasy (MDMA) effects upon mood and cognition; before, during, and after a Saturday night dance. Psychopharmacology139: 261–268.
23.
ParrottACLockJConnerACKisslingCThomeJ (2008) Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology57: 165–180.
24.
RenemanLde WinMMvan den BrinkWBooijJden HeetenGJ (2006) Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol20: 164–175.
25.
WolfOTDziobekIMcHughPSweatVde LeonMJJavierE. (2005) Subjective memory complaints in aging are associated with elevated cortisol levels. Neurobiol Aging26: 1357–1363.
26.
WolffKTsapakisEMWinstockARHartleyDHoltDForslingML. (2006) Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol20: 400–410.
27.
WolffKTsapakisEMParianteCMKerwinRWForslingMLAitchisonKJ (2012) Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. J Psychopharmacol26: 419–428.
